CRX-675

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameCRX-675
Drug Alias NameCRX-675
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionToll like receptor 4 agonists
TargetsToll like receptor 4
Therapy Area/IndicationsRhinitis, Allergic, Seasonal
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline Plc
Active IndicationsN/A
Inactive IndicationsRhinitis, Allergic, Seasonal

Other Information

ATC CodeN/A
Related LinksN/A